NCT00969631View on ClinicalTrials.gov

Combined Metformin and Clomiphene Citrate (CC) or Laparoscopic Ovarian Diathermy for Women With CC Resistant Polycystic Ovary Syndrome (PCOS)

NACompletedINTERVENTIONAL
Enrollment

282

Participants

Timeline

Start Date

September 30, 2005

Primary Completion Date

February 28, 2009

Study Completion Date

February 28, 2009

Conditions
Polycystic Ovary Syndrome
Interventions
DRUG

metformin HCl (Cidophage®; CID,Cairo, Egypt), CC (Clomid®; Global Napi Pharmaceuticals,Cairo, Egypt),Cairo, Egypt)

metformin HCl 1500 daily for 6-8 weeks then 100 mg CC for 5 days starting from day 3 of menstruation up to 6 cycles.

PROCEDURE

Laparoscopic ovarian diathermy (LOD)

Three-puncture technique. Each ovary was cauterized at four points, each for 4 seconds at 40 W for a depth of 4 mm with a mixed current, using an monopolar electrosurgical needle.

Trial Locations (1)

Unknown

Mansoura University Hospitals, OB/GYN department, Al Mansurah

All Listed Sponsors
lead

Mansoura University

OTHER

NCT00969631 - Combined Metformin and Clomiphene Citrate (CC) or Laparoscopic Ovarian Diathermy for Women With CC Resistant Polycystic Ovary Syndrome (PCOS) | Biotech Hunter | Biotech Hunter